...Good afternoon, everyone, and welcome back to H.C. Wainwright's Cell Therapy Virtual Conference. My name is Patrick Trucchio. I'm a senior biotech analyst at H.C. Wainwright. And it's my pleasure to introduce our next speakers: Michael Amoroso, CEO; Derek Jantz, CSO; and Alan List, CMO of Precision BioSciences, a clinical-stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies. And with that, I'll hand over the presentation to Michael for the introduction. Michael Amoroso ...